Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Management of the Primary Tumor and Limited Metastases in Patients With Metastatic Pancreatic Cancer.

Herman JM, Hoffman JP, Thayer SP, Wolff RA.

J Natl Compr Canc Netw. 2015 May;13(5):e29-36. Review.

PMID:
26158133
2.

Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.

Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, Nishiyama K.

Ann Surg. 2009 Jul;250(1):88-95. doi: 10.1097/SLA.0b013e3181ad65cc.

PMID:
19561477
3.

Management of Metastatic Pancreatic Adenocarcinoma.

Cheema AR, O'Reilly EM.

Surg Clin North Am. 2016 Dec;96(6):1391-1414. doi: 10.1016/j.suc.2016.07.011. Review.

PMID:
27865284
4.

Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.

Falchook GS, Wolff RA, Varadhachary GR.

Gynecol Oncol. 2008 Mar;108(3):515-9. doi: 10.1016/j.ygyno.2007.11.012.

PMID:
18164378
5.

Multidisciplinary management of advanced primary and metastatic breast cancer.

Hortobagyi GN.

Cancer. 1994 Jul 1;74(1 Suppl):416-23. Review.

PMID:
8004615
6.

Approach to patients with pancreatic cancer without detectable metastases.

Heestand GM, Murphy JD, Lowy AM.

J Clin Oncol. 2015 Jun 1;33(16):1770-8. doi: 10.1200/JCO.2014.59.7930. Epub 2015 Apr 27. Review.

PMID:
25918279
7.

Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.

Aristu J, Cañón R, Pardo F, Martínez-Monge R, Martin-Algarra S, Manuel Ordoñez J, Villafranca E, Moreno M, Cambeiro M, Azinovic I.

Am J Clin Oncol. 2003 Feb;26(1):30-6.

PMID:
12576921
8.

Advancements in the management of pancreatic cancer: 2013.

Saif MW.

JOP. 2013 Mar 10;14(2):112-8. doi: 10.6092/1590-8577/1481.

9.

Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer.

Hunter KU, Feng FY, Griffith KA, Francis IR, Lawrence TS, Desai S, Murphy JD, Zalupski MM, Ben-Josef E.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):921-6. doi: 10.1016/j.ijrobp.2011.08.022. Epub 2011 Dec 28.

PMID:
22208966
10.

Pancreatic neoplasm in 2011: an update.

Saif MW.

JOP. 2011 Jul 8;12(4):316-21. Review.

11.

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.

Morizane C, Okusaka T, Furuse J, Ishii H, Ueno H, Ikeda M, Nakachi K, Najima M, Ogura T, Suzuki E.

Cancer Chemother Pharmacol. 2009 Jan;63(2):313-9. doi: 10.1007/s00280-008-0741-7. Epub 2008 Apr 9.

PMID:
18398614
12.

Adjuvant chemoradiotherapy for high-risk pancreatic cancer.

Wang ML, Foo KF.

Singapore Med J. 2009 Jan;50(1):43-8.

13.

Implications of peritoneal cytology for pancreatic cancer management.

Makary MA, Warshaw AL, Centeno BA, Willet CG, Rattner DW, Fernández-del Castillo C.

Arch Surg. 1998 Apr;133(4):361-5.

PMID:
9565114
14.

Primary advanced unresectable pancreatic cancer.

Wilkowski R, Wolf M, Heinemann V.

Recent Results Cancer Res. 2008;177:79-93. Review.

PMID:
18084950
15.

Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.

Wilkowski R, Thoma M, Bruns C, Dühmke E, Heinemann V.

JOP. 2006 Jan 11;7(1):34-40.

16.

Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma.

Bakshandeh-Bath A, Stoltz AS, Homann N, Wagner T, Stölting S, Peters SO.

Anticancer Res. 2009 Aug;29(8):3069-77.

17.

Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.

Schuricht AL, Spitz F, Barbot D, Rosato F.

Am Surg. 1998 Nov;64(11):1043-9.

PMID:
9798766
18.
19.

Multicenter phase II study of gemcitabine and S-1 combination therapy (GS Therapy) in patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, Yokosuka O, Tanaka K, Moriyasu F, Nakamori S, Sato T.

Jpn J Clin Oncol. 2011 Aug;41(8):953-8. doi: 10.1093/jjco/hyr090. Epub 2011 Jun 29.

PMID:
21715364
20.

Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.

Wilkowski R, Thoma M, Bruns C, Wagner A, Heinemann V.

JOP. 2006 Jul 10;7(4):349-60.

Supplemental Content

Support Center